This bill amends 21 U.S.C. 823(h) to make registration or continued registration for opioid maintenance and detoxification programs contingent on a set of community-oriented requirements. Applicants must demonstrate patient need, avoid designated sensitive sites within a half-mile, promote telehealth, appoint a community liaison, coordinate with local customer-relationship management systems, create neighborhood engagement plans and community advisory boards, and report performance data to the Secretary.
The change shifts part of the registration assessment from a primarily medical and regulatory inquiry to a hybrid that formally weighs neighborhood impacts and community input. That creates new compliance obligations for clinics and a new oversight stream for the Secretary, plus an annual congressional reporting duty on outcomes, best practices, and policy recommendations — all of which can materially affect siting, operations, and access to treatment in both urban and rural areas.
At a Glance
What It Does
The bill augments the Controlled Substances Act registration standard for opioid treatment programs by adding community-impact criteria: outreach and notice to local stakeholders, a neighborhood engagement plan, a community advisory board, a community relations plan to address quality-of-life concerns, telehealth promotion, CRM data coordination with local government, and reporting of specified treatment performance metrics. It also bars siting within one-half mile of schools, day cares, playgrounds, or other treatment facilities.
Who It Affects
Opioid treatment program operators and applicants seeking DEA/Secretary registration for maintenance or detox services, local governments that operate customer-relationship management systems, community-based organizations listed as stakeholders, and the Secretary responsible for registration determinations and annual reports to Congress.
Why It Matters
This is a regulatory pivot that embeds formal community engagement and local data flows into federal registration for addiction treatment, potentially changing where and how clinics operate and creating new administrative and reporting burdens. It also creates an explicit federal role in measuring telehealth use and patient movement into long-term treatment.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill rewrites the registration requirements for practitioners and programs that dispense narcotic drugs for maintenance or detoxification by adding a set of community-focused conditions the Secretary must consider before granting or renewing registration. Rather than merely meeting qualification and facility standards, applicants must now show they will engage proactively with local stakeholders and take steps to minimize negative community impacts.
Practically, applicants must conduct outreach and provide notice to a defined set of local stakeholders — for example, community boards, tenant associations, outpatient centers, local nonprofits that deliver overdose prevention services, and other stakeholders the Secretary names. They must produce a neighborhood engagement plan describing how they will interact with neighbors and local institutions, and they must form and maintain a community advisory board composed of local volunteers from varied stakeholder groups.The bill also imposes operational and siting conditions: programs cannot operate within one-half mile of day-care centers, elementary or secondary schools, learning centers, playgrounds, or other drug treatment facilities (including supervised injection sites).
Applicants must justify local patient need, promote telehealth to reduce in-person visits, designate a community liaison to coordinate with elected officials and law enforcement, and either join an existing local customer-relationship management (CRM) system or set one up to track community service requests on drug abuse and treatment.Finally, the Secretary must collect program performance metrics — notably how many patients seek effective long-term addiction treatment and metrics on telehealth use and outcomes — and submit an initial report within one year and annual reports thereafter to Congress with data, best-practice guidance, and policy recommendations. Those reporting and data-collection duties create a feedback loop intended to measure whether the added community engagement requirements affect access, outcomes, or neighborhood quality of life.
The Five Things You Need to Know
The bill adds a one-half-mile exclusion: registered programs may not be located within 0.5 miles of licensed day cares, elementary or secondary schools, learning centers, playgrounds, or another drug treatment facility (including supervised injection facilities).
Applicants must join or create a local government customer-relationship management (CRM) system to log and report community service requests related to drug abuse and treatment in the program’s area.
Every registrant must establish and maintain a community advisory board composed of local volunteers representing surrounding stakeholders as a condition of registration.
The Secretary must receive performance measurement data that include counts of patients seeking long-term addiction treatment and telehealth usage and outcomes; the Secretary must issue an initial report within one year and then annual reports to Congress.
Registration requires a designated community liaison who will develop and maintain cooperative relationships with local elected officials, law enforcement, and community-based organizations, and a neighborhood engagement plan addressing issues such as loitering and pedestrian obstruction.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Reformats paragraph and establishes scope for new registration standard
The bill reorganizes the existing paragraph structure of 21 U.S.C. 823(h) to create a numbered framework and explicitly labels the provision governing maintenance/detoxification registration as subject to new requirements. This mechanical change is the wiring that lets the new substantive tests — community impact and related conditions — plug into the existing registration scheme.
New checklist the Secretary must apply before granting or renewing registration
This subsection lists discrete determinations the Secretary must make about an applicant: that the program will address community impacts, will not be sited within one-half mile of enumerated sensitive facilities, will justify patient need in the community, will actively promote telehealth, will appoint a community liaison, will participate in a local CRM system, and will report specified performance metrics. Each item is a separate statutory gate; failure on any could justify denial or nonrenewal, which raises compliance and evidentiary questions for applicants.
Outreach, neighborhood engagement plans, and community advisory boards
This new paragraph requires applicants to conduct outreach and give notice to an enumerated set of stakeholders, prepare a neighborhood engagement plan describing ongoing interactions with local groups, and create a community advisory board made up of local volunteer representatives. It also requires a community relations plan with concrete procedures to address problems like loitering, blocked pedestrian pathways, open-air drug trading, uncapped needles, and open drug use — moving community-quality-of-life mitigation into the center of the registration analysis.
Annual Secretary reports with data, best practices, and policy recommendations
The Secretary must deliver an initial comprehensive report within one year and then annually to Congress covering community engagement activities and clinic maintenance, including treatment performance metrics and guidance on sustaining engagement. That creates a statutory obligation to synthesize program-level data into national guidance and policy recommendations, which may inform future regulatory or statutory changes.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Local community organizations and residents — they get a formal seat at the table through required notice, community advisory boards, neighborhood engagement plans, and a designated liaison, making it easier to raise and escalate quality-of-life concerns to the program and the Secretary.
- Local government agencies — the bill creates a role for municipal CRM systems to capture service requests related to drug abuse and treatment, improving local situational awareness and data-driven responses.
- Policymakers and researchers — mandatory reporting of telehealth metrics and counts of patients seeking long-term treatment creates standardized data that can be analyzed to assess treatment access, outcomes, and the community impacts of OTPs.
Who Bears the Cost
- Opioid treatment program operators and applicants — they must develop and maintain outreach programs, neighborhood engagement and community relations plans, community advisory boards, a designated liaison, CRM integration, and the data-collection systems to report performance metrics; these requirements add staff time and potential capital costs and could complicate siting.
- The Secretary (and statutory oversight office) — the agency must adjudicate the new discretionary determinations, collect and validate performance data from registrants, and produce annual reports to Congress, tasks that require staffing and analytic resources.
- Patients seeking treatment — in some communities the siting buffer and additional registration hurdles could reduce the number of available clinics, potentially increasing travel distances or wait times for people seeking immediate care.
Key Issues
The Core Tension
The central dilemma is balancing neighborhood quality-of-life concerns and community input against timely, geographically accessible harm-reduction treatment: the bill empowers communities and local governments to shape whether and how clinics operate, but those same measures risk reducing clinic availability for people with opioid use disorder unless the Secretary calibrates standards to preserve access.
The bill trades a straightforward medical-regulatory registration standard for a multifaceted public-engagement and neighborhood-quality test that requires subjective determinations. Key implementation questions follow: who within the Executive Branch will set uniform standards for what adequate outreach, engagement plans, or community advisory boards look like; what evidentiary showing will satisfy the Secretary’s requirement that an applicant “justify patient need;” and how the Secretary will verify CRM entries and program-supplied performance metrics.
Operational tensions arise around siting and access. A half-mile exclusion is simple to apply on a map, but in dense urban neighborhoods it can make compliance infeasible and concentrate patients in fewer locations.
Programs in rural areas may face different constraints: the buffer may be irrelevant where sensitive facilities are sparse, but the data, outreach, and CRM expectations still impose fixed costs. Data collection and CRM integration also raise privacy and interoperability concerns, particularly if local CRM systems record community complaints that touch on patient behavior; the bill does not specify safeguards or limits on the types of data to be shared with local governments or with the Secretary.
Finally, the emphasis on telehealth is double-edged. Promoting telehealth can reduce foot traffic and neighborhood disturbance, but many OTPs rely on in-person dispensing and supervised administration for clinical and regulatory reasons.
The bill requires promotion and measurement of telehealth without reconciling telemedicine’s limits in opioid treatment (for example, medication dispensing logistics and state-controlled substance rules), leaving unresolved how much telehealth uptake is feasible or how the Secretary should weigh telehealth metrics against demonstrated local patient need.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.